Obstet Gynecol Sci.  2022 Jan;65(1):74-83. 10.5468/ogs.21235.

Outcomes of vaginal hysterectomy combined with anterior and posterior colporrhaphy for pelvic organ prolapse: a single center retrospective study

• Kim JH
• Lee SY
• Chae HD
• Shin YK
• Lee SR
• Kim SH

• KMID: 2524687
• DOI: http://doi.org/10.5468/ogs.21235

Abstract

Objective
To evaluate the efficacy of vaginal hysterectomy combined with anterior and posterior colporrhaphy (VH APR) for the management of pelvic organ prolapse (POP).
Methods
A total of 610 patients with POP who underwent VH APR from January 2010 to June 2019 at Asan Medical Center were included in this study. We analyzed the patient characteristics and surgical outcomes. In addition, we compared the POP quantification system (POP-Q) pre- and postoperatively at 2 weeks, 3 months, and 1 year, and analyzed the risk factors for recurrence.
Results
The mean age of the patients was 65.5±7.6 years. The most common preoperative POP-Q stage was stage 2 (60.8%), followed by stage 3 (35.9%). Complications were identified during surgery in 1.6% of the patients. The most common postoperative complication (6.4%) was voiding difficulty. All POP-Q scores significantly decreased at 1 year after surgery (P<0.0001). The recurrence rate was 9.6%, and most recurrences (77.5%) occurred in the anterior compartment. An advanced stage of preoperative POP was a risk factor for recurrence (stage 3 or 4 vs. stage 1 or 2; odds ratio [OR], 5.337, 95% confidence interval [CI], 2.58-11.036, P<0.0001). Only two patients underwent surgical correction for POP recurrence, and most of the remaining patients did not undergo further treatment for prolapse.
Conclusion
VH APR is a safe and effective surgical procedure for POP, with a low recurrence rate. In addition, advanced preoperative stage was the only risk factor for recurrent POP.

Keyword

Vaginal hysterectomy; Pelvic organ prolapse; Anterior colporrhaphy; Posterior colporrhaphy

Figure

• 

  Fig. 1 Comparison of the postperative POP-Q system at 2 weeks, 3 months, and 1 year after surgery. POP-Q, pelvic organ prolapse quantification.

Reference

References

1. Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007; 369:1027–38.

2. Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the women’s health initiative: gravity and gravidity. Am J Obstet Gynecol. 2002; 186:1160–6.

3. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008; 300:1311–6.

4. Rortveit G, Brown JS, Thom DH, Van Den Eeden SK, Creasman JM, Subak LL. Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort. Obstet Gyneco. 2007; 109:1396–403.

5. Tegerstedt G, Maehle-Schmidt M, Nyrén O, Hammarström M. Prevalence of symptomatic pelvic organ prolapse in a Swedish population. Int Urogynecol J Pelvic Floor Dysfunct. 2005; 16:497–503.

6. Kim SH. Diagnosis and treatment of pelvic organ prolapse. Korean J Obstet Gynecol. 2006; 49:501–12.

7. Yuk JS, Lee JH, Hur JY, Shin JH. The prevalence and treatment pattern of clinically diagnosed pelvic organ prolapse: a Korean National Health Insurance Database-based cross-sectional study 2009–2015. Sci Rep. 2018; 8:1334.

8. Dietz HP. Prolapse worsens with age, doesn’t it? Aust N Z J Obstet Gynaecol. 2008; 48:587–91.

9. Inal ZO, Inal HA. Comparison of abdominal, vaginal, and laparoscopic hysterectomies in a tertiary care hospital in Turkey. Ir J Med Sci. 2018; 187:485–91.

10. Roovers JP, van der Bom JG, van der Vaart CH, Schagen van Leeuwen JH, Heintz AP. Abdominal versus vaginal approach for the management of genital prolapse and coexisting stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2002; 13:224–31.

11. Johnson N, Barlow D, Lethaby A, Tavender E, Curr E, Garry R. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2005; (1):CD003677.

12. Jeon MJ. Surgical decision making for symptomatic pelvic organ prolapse: evidence-based approach. Obstet Gynecol Sci. 2019; 62:307–12.

13. Dallas K, Elliott CS, Syan R, Sohlberg E, Enemchukwu E, Rogo-Gupta L. Association between concomitant hysterectomy and repeat surgery for pelvic organ prolapse repair in a cohort of nearly 100,000 women. Obstet Gynecol. 2018; 132:1328–36.

14. Glazener CM, Breeman S, Elders A, Hemming C, Cooper KG, Freeman RM, et al. Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT). Lancet. 2017; 389:381–92.

15. Dos Reis Brandão da Silveira S, Haddad JM, de Jármy-Di Bella ZI, Nastri F, Kawabata MG, da Silva Carramão S, et al. Multicenter, randomized trial comparing native vaginal tissue repair and synthetic mesh repair for genital prolapse surgical treatment. Int Urogynecol J. 2015; 26:335–42.

16. Ko KJ, Lee KS. Current surgical management of pelvic organ prolapse: strategies for the improvement of surgical outcomes. Investig Clin Urol. 2019; 60:413–24.

17. Mowat A, Maher D, Baessler K, Christmann-Schmid C, Haya N, Maher C. Surgery for women with posterior compartment prolapse. Cochrane Database Syst Rev. 2018; 3:CD012975.

18. Roovers JP, van der Vaart CH, van der Bom JG, van Leeuwen JH, Scholten PC, Heintz AP. A randomised controlled trial comparing abdominal and vaginal prolapse surgery: effects on urogenital function. BJOG. 2004; 111:50–6.

19. Persu C, Chapple CR, Cauni V, Gutue S, Geavlete P. Pelvic organ prolapse quantification system (POP-Q) - a new era in pelvic prolapse staging. J Med Life. 2011; 4:75–81.

20. Ismail S, Duckett J, Rizk D, Sorinola O, Kammerer-Doak D, Contreras-Ortiz O, et al. Recurrent pelvic organ prolapse: International Urogynecological Association research and development committee opinion. Int Urogynecol J. 2016; 27:1619–1632.

21. Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Brown J. Surgery for women with anterior compartment prolapse. Cochrane Database Syst Rev. 2016; 11:CD004014.

22. Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Brown J. Surgery for women with apical vaginal prolapse. Cochrane Database Syst Rev. 2016; 10:CD012376.

23. Nager CW, Visco AG, Richter HE, Rardin CR, Rogers RG, Harvie HS, et al. Effect of vaginal mesh hysteropexy vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: a randomized clinical trial. JAMA. 2019; 322:1054–65.

24. O’Leary BD, Dempsey M, Agnew GJ. Blood transfusion after vaginal hysterectomy for pelvic organ prolapse. Ir J Med Sci. 2019; 188:265–6.

25. Otton GR, Mandapati S, Streatfeild KA, Hewson AD. Transfusion rate associated with hysterectomy for benign disease. Aust N Z J Obstet Gynaecol. 2001; 41:439–42.

26. Nelson NC, Ostby SA, Weaver AL, McGree ME, Gebhart JB, Bakkum-Gamez JN. Estimated blood loss during vaginal hysterectomy and adnexal surgery described with an intraoperative pictographic tool. Female Pelvic Med Reconstr Surg. 2018; 24:347–51.

27. Clarke-Pearson DL, Geller EJ. Complications of hysterectomy. Obstet Gynecol. 2013; 121:654–73.

28. Chong C, Kim HS, Suh DH, Jee BC. Risk factors for urinary retention after vaginal hysterectomy for pelvic organ prolapse. Obstet Gynecol Sci. 2016; 59:137–43.

29. Mathevet P, Valencia P, Cousin C, Mellier G, Dargent D. Operative injuries during vaginal hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2001; 97:71–5.

30. Vergeldt TF, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J. 2015; 26:1559–73.